Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

Genmab shares surged after its experimental ovarian cancer treatment showed promising results in a late-stage trial.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.